[{"address1": "Life Science & Technology Park", "address2": "Suite  520 1951 NW 7th Avenue", "city": "Miami", "state": "FL", "zip": "33136", "country": "United States", "phone": "844 470 2550", "website": "https://longeveron.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States and Japan. The company's lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors. It is conducting Phase 1, Phase 1/2, Phase 2a, and Phase 2b clinical trials in various indications, such as aging-related frailty, alzheimer's disease, and hypoplastic left heart syndrome. Longeveron Inc. was incorporated in 2014 and is headquartered in Miami, Florida.", "fullTimeEmployees": 23, "companyOfficers": [{"maxAge": 1, "name": "Dr. Joshua Michael Hare FACC, M.D.", "age": 60, "title": "Co-Founder, Chief Science Officer & Chairman", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 74000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mohamed Wa'el Ahmed Hashad M.B.A.", "age": 61, "title": "CEO & Director", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 867854, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lisa A. Locklear M.B.A.", "age": 61, "title": "CFO & Treasurer", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 472272, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul T. Lehr J.D.", "age": 55, "title": "International Executive Director, General Counsel & Secretary", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 554055, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Dan  Gincel Ph.D.", "age": 52, "title": "Senior Vice President of Strategic Collaborations & Scientific Affairs", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Nataliya  Agafonova M.D.", "age": 54, "title": "Chief Medical Officer", "yearBorn": 1969, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Elly  Ryu", "age": 42, "title": "VP & Corporate Controller", "yearBorn": 1981, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael  Mannarino", "title": "VP & Corporate Controller", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 2.06, "open": 2.05, "dayLow": 2.0, "dayHigh": 2.1, "regularMarketPreviousClose": 2.06, "regularMarketOpen": 2.05, "regularMarketDayLow": 2.0, "regularMarketDayHigh": 2.1, "beta": 0.365, "forwardPE": -1.3137255, "volume": 327111, "regularMarketVolume": 327111, "averageVolume": 4862712, "averageVolume10days": 511720, "averageDailyVolume10Day": 511720, "bid": 1.97, "ask": 2.05, "bidSize": 100, "askSize": 100, "marketCap": 28862594, "fiftyTwoWeekLow": 0.771, "fiftyTwoWeekHigh": 26.7, "priceToSalesTrailing12Months": 23.484617, "fiftyDayAverage": 2.738, "twoHundredDayAverage": 5.36235, "currency": "USD", "enterpriseValue": 18953524, "floatShares": 11234281, "sharesOutstanding": 12875500, "sharesShort": 733478, "sharesShortPriorMonth": 1378548, "sharesShortPreviousMonthDate": 1722384000, "dateShortInterest": 1724976000, "sharesPercentSharesOut": 0.0511, "heldPercentInsiders": 0.10824, "heldPercentInstitutions": 0.025729999, "shortRatio": 0.71, "shortPercentOfFloat": 0.0588, "bookValue": 1.553, "priceToBook": 1.2942692, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -27904000, "trailingEps": -8.86, "forwardEps": -1.53, "enterpriseToRevenue": 15.422, "enterpriseToEbitda": -1.101, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "LGVN", "underlyingSymbol": "LGVN", "shortName": "Longeveron Inc.", "longName": "Longeveron Inc.", "firstTradeDateEpochUtc": 1613140200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "0810e7c7-ed9c-3408-947e-be0c34d084bb", "gmtOffSetMilliseconds": -14400000, "currentPrice": 2.01, "targetHighPrice": 10.0, "targetLowPrice": 6.0, "targetMeanPrice": 8.32, "targetMedianPrice": 8.95, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 3, "totalCash": 12375000, "totalCashPerShare": 0.862, "ebitda": -17219000, "totalDebt": 1748000, "quickRatio": 3.923, "currentRatio": 4.178, "totalRevenue": 1229000, "debtToEquity": 11.723, "revenuePerShare": 0.364, "returnOnAssets": -0.62243, "returnOnEquity": -1.42164, "freeCashflow": -10034000, "operatingCashflow": -16205000, "revenueGrowth": 1.157, "grossMargins": 0.58991003, "operatingMargins": -7.4786296, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-17"}]